NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rimonci

Rimonci

Beijing, Beijingrimonci.com

Overview

Rimonci Capital is a venture capital firm focused on visual science innovation, investing in early-stage companies in ophthalmology, optometry, and neuro-ophthalmology across the U.S., Israel, Europe, and Greater China. Founded in 2016, it supports advancements in medical and IT solutions, leveraging its expertise and ecosystem to drive clinical and commercial success in the visual science field.

Year Founded

2016

Portfolio Companies

6

Investments

Rimonci investments
CompanyDateStageLead
TECLens, Inc.Feb 2025Series ACo-investor
EyeYon MedicalMar 2021Series CCo-investor
EyeControlAug 2020Series ACo-investor
NovaSightJul 2020Series ALead
Galimedix TherapeuticsJan 2019SeedCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing, Beijing
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.